Coronavirus | Pfizer-BioNTech begin global study of lead vaccine candidate
The study is expected to include about 120 sites globally and could include up to 30,000 participants.
Full Article
Coronavirus | Pfizer-BioNTech begin global study of lead vaccine candidate
Hindu
0 shares
1 views
You might like
Related news coverage
Why Are We Ignoring The Coming Autism Avalanche? – OpEd
Eurasia Review
By Pennel Bird*
Back in the year 2000 at the dawn of the new millennium, as Y2K fears faded to thin transparencies in..
-
FTSE 100 clinging on to gains as sterling rallies
Proactive Investors
-
FTSE 100 shrugs off latest episode in US-China muscle-flexing contest
Proactive Investors
Advertisement
More coverage
Who Wants To Be A Great Power? – Analysis
Eurasia Review
By Lawrence Freedman*
Strategic competition is back in vogue. After years of worrying about ethnic conflict and..
-
NA Proactive news snapshot: Ipsidy, Avalon GloboCare, BioSig Technologies, Co-Diagnostics, Black Iron, Thunderbird Entertainment UPDATE …
Proactive Investors
-
NA Proactive news snapshot: Thunderbird Entertainment, District Metals, GlobeX Data, Champignon Brands, Ipsidy UPDATE …
Proactive Investors
-
NA Proactive news snapshot: CytoDyn, Weekend Unlimited, Essex Minerals, Innocan Pharma ...
Proactive Investors
-
FSD Pharma announces US$20M offering to help fund research on lead drug candidate FSD-201
Proactive Investors